Ann: Placement Settlement Complete, Info on the Priority Offer, page-5

First 5 Last

Share
Profile

Follow
Cbyrne11

1,776 Posts.

36

29/08/19

15:54

Post #: 40223242
Share

Originally posted by ashc15: ↑

They've done a great job with this. Efficiently raised and with regular shareholders able to participate for a portion. With the receivables due this qtr, IMO this will jump after the next qtrly.

I can understand frustrations over the dilution/sp drop that comes with a CR, but evidently this thread as quite a few illogical, overemotional whiners.

The MM industry is in its infancy and this is a spec stock. CRs and losses are part of the building process at this end of the market. It's a long hold and that has always been what the company has communicated. For a spec stock, MXC has done brilliantly this year and IMO they're well ahead of their ASX competitors. I'm not sure how one can read the milestones in the annual report and not be pleased:

- Pioneer in the R&D side with great partnerships and key projects on the go.
- Actual Pharma products on the market and generating revenue. Agreements signed worldwide to ensure delivery of our product is achievable as brand, product and industry awareness grows. We have literally only been in this phase for a few months and if you believe in the MM industry outlook, this is only going to grow.
- Side operations generating revenue through raw material supply agreements
- Malta facility lined up

I find it funny how 2019 has been positive progress all the way, and then a necessary CR comes and people cry 'Second Strike' and 'Fake Company'. These people should only be disappointed in their poor understanding of the market and the growth timeline of this industry. Apart from a necessary CR now, what negatives have come from FY19?

I also think the LSE listing will be positive. Our brand and operations are bigger in Europe than here. The MM in Aus will be a slower burn, because we are lagging behind in this space. Europe is a much bigger market, with much higher potential returns.

Expand

only real measure of how a stuck is doing is the share price, currently it is sitting well below what it was a year ago. So despite the string of good announcements the market has zero confidence in this stock.

MXC Price at posting: 4.0¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

What's causing the cost-of-living crisis, and how to navigate it

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%